Find your next paid study

Chronic Obstructive Pulmonary Disease

~$10 – $7,500

AstraZenecaNCT07391657

Observational

Developing an Intervention to Optimize Virtual Care Adoption for COPD Management (CDA 21-187)

VA is a leader in virtual care (VC), including the patient portal, mobile apps, and telehealth programs. VC has great utility for managing chronic conditions l…

VA Office of Research and DevelopmentNCT05986214

Colorectal AdenocarcinomaStage II Colorectal Cancer AJCC v8Stage III Colorectal Cancer AJCC v8

A Phase 2 Study of Microsatellite Stable Colorectal Cancer (Stage 2 or 3) With Radiographic Occult Molecular Residual Disease Treated With Botensilimab (AGEN1181; Bot) Plus Balstilimab (AGEN2034, Bal) After Established Definitive Therapy (COMBAT Study)

This phase II trial tests the effect of the botensilimab in combination with balstilimab in treating patients with stage II/III colorectal adenocarcinoma with …

National Cancer Institute (NCI)NCT07551596

Respiratory Syncytial Virus Infections

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety, Tolerability, and Efficacy of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus Who Are at High Risk of Progression to Severe Disease

The main purpose of this study is to investigate the antiviral effect of S-337395 compared with placebo among nonhospitalized adult participants with high-risk…

Heart FailureHeart Failure With Preserved Ejection Fraction

~$10 – $7,500

ShionogiNCT07214571

HeartShare Deep Phenotyping Study

HeartShare is a comprehensive study of heart failure, a common and serious medical condition which occurs when the heart is unable to keep up with the demands …

Northwestern UniversityNCT05873634

~$10 – $750

Phase 1

Phase I Trial of ZEN003694 (ZEN-3694) in Combination With Capecitabine in Patients With Solid Tumors

This phase I trial tests the safety, side effects, and best dose of ZEN003694 in combination with the usual treatment with capecitabine in treating patients wi…

Metastatic Colorectal CarcinomaMetastatic Malignant Solid NeoplasmStage IV Colorectal Cancer AJCC v8+2 more

National Cancer Institute (NCI)NCT05803382

Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies (TG-INSIGHT With Joint POCUS)

This is an observational research study to find out if there is a difference in the way children with moderate or severe hemophilia A, treated on two different…

Hemophilia AFactor VIII (FVIII)

University of Texas Southwestern Medical CenterNCT07692217

~$10 – $750

Healthy VolunteerWeight GainMetabolic Effects+1 more

Early Metabolic Effects of Antiretroviral Drugs in Healthy Volunteers: A Phase 2 Randomized Study

Background: People with HIV take drugs to keep the amount of virus in their body low. One type of these drugs, called integrase strand transfer inhibitors (IN…

National Institute of Allergy and Infectious Diseases (NIAID)NCT05652478

Allogeneic Hematopoietic Cell Transplantation for Refractory Systemic Juvenile Idiopathic Arthritis: A Single-Center Prospective Trial

The goal of this study is to collect clinical data and samples and to evaluate the feasibility of allogeneic hematopoietic cell transplantation (HCT) in childr…

Refractory Systemic Juvenile Idiopathic ArthritisSystemic Juvenile Idiopathic ArthritisSystemic Juvenile Idiopathic Arthritis Associated Lung Disease

Children's Hospital Medical Center, CincinnatiNCT07845942

~$10 – $675

Observational

Can Heat Therapy Improve Cardiovascular Health During Periods of Reduced Physical Activity?

The purpose of this randomized controlled trial is to determine whether daily Finnish dry sauna therapy attenuates the adverse cardiovascular, muscular, and me…

Physical InactivityVascular DysfunctionSkeletal Muscle Atrophy

Brigham Young UniversityNCT07847424

~$10 – $6,250

Conjunctival Mucosa-Associated Lymphoid Tissue LymphomaGastric Mucosa-Associated Lymphoid Tissue LymphomaMarginal Zone Lymphoma+4 more

A Phase II Study of the Non-Covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab in Patients With Marginal Zone Lymphoma

This phase II trial tests the effect of nemtabrutinib in combination with rituximab in treating patients with marginal zone lymphoma. Nemtabrutinib, a non-cova…

City of Hope Medical CenterNCT07583810

~$10 – $6,250

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Panzyga for Prevention of Major Infection in Patients With Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions Receiving Treatment With B-cell Depletion Therapy ("PROTECT")

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Panzyga for Prevention of Major Infection in Pa…

HypogammaglobulinemiaAutoimmune ConditionsRheumatic Conditions+1 more